WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 35 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,644 | -29.8% | 50,768 | 0.0% | 0.00% | – |
| Q2 2023 | $154,842 | +17.3% | 50,768 | 0.0% | 0.00% | – |
| Q1 2023 | $131,997 | -2.3% | 50,768 | -23.0% | 0.00% | – |
| Q4 2022 | $135,168 | +21.8% | 65,936 | +168.4% | 0.00% | – |
| Q3 2022 | $111,000 | +11.0% | 24,568 | 0.0% | 0.00% | – |
| Q2 2022 | $100,000 | -93.2% | 24,568 | -92.7% | 0.00% | – |
| Q1 2022 | $1,474,000 | -52.3% | 335,087 | +29.1% | 0.00% | – |
| Q4 2021 | $3,092,000 | +55.2% | 259,626 | +123.7% | 0.00% | – |
| Q3 2021 | $1,992,000 | +46.0% | 116,064 | +48.3% | 0.00% | – |
| Q2 2021 | $1,364,000 | – | 78,237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,531,665 | 35.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $11,138,847 | 4.64% |
| MPM BioImpact LLC | 2,388,011 | $6,208,829 | 1.61% |
| RA Capital Management | 6,144,881 | $15,976,691 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,629,706 | 0.27% |
| PFM Health Sciences, LP | 2,217,220 | $5,764,772 | 0.26% |
| Rubric Capital Management LP | 1,935,357 | $5,031,928 | 0.13% |
| Laurion Capital Management LP | 522,900 | $1,359,540 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $1,034,301 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 81,711 | $212,449 | 0.01% |